Health
$160,000 drug for multiple myeloma blood cancer added to PBS at a cost to patients of $480 – The New Daily
More than 1000 patients with an incurable blood cancer are expected to benefit from a “completely new” treatment subsidised by the federal government.
More than 1000 patients with an incurable type of blood cancer are expected to benefit from a “completely new” treatment that will be subsidised by the federal government in the new year.
Darzalex, which will be listed on the Pharmaceutical Benefits Scheme (PBS) from January 1, is a medicine used to treat multiple myeloma, a cancer that causes cancerous plasma cells to accumulate in bone marrow and crowd out healthy blood cells.
An estimated 18,000 to 20,000 people are living with multiple myeloma…
-
Noosa News14 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General13 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General15 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News17 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate